0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2006;296(3):251. doi:10.1001/jama.296.3.251.
Text Size: A A A
Published online

WOMEN, MIGRAINE, AND CARDIOVASCULAR DISEASE

Migraine, particularly migraine with aura, is associated with an increased risk of ischemic stroke, but whether migraine is associated with other ischemic vascular events is not clear. In an analysis of data from a prospective study of healthy middle-aged women, Kurth and colleaguesArticle examined the association of migraine with subsequent risk of overall and specific cardiovascular disease (CVD). The authors found that compared with women with no migraine history, any history of migraine was associated with increased risk of CVD. Active migraine with aura was associated with increased risks of major CVD, ischemic stroke, myocardial infarction, death from ischemic CVD, coronary revascularization, and angina, whereas active migraine without aura was not associated with increased risk of these CVD events. In an editorial, Lipton and BigalArticle discuss possible explanations for these findings and their clinical implications.

INCIDENCE OF INFECTIONS IN HIV-INFECTED CHILDREN

Highly active antiretroviral therapy (HAART) has resulted in dramatic declines in opportunistic and other infections in adults and children infected with human immunodeficiency virus (HIV), but no studies have compared pediatric infection rates in the HAART vs pre-HAART eras. Gona and colleaguesArticle analyzed data from a prospective study of US children infected with HIV to estimate the incidence rates for first occurrence of 29 opportunistic or other infections between January 2001 and December 2004 and compared these with infection rates in the pre-HAART era. The authors report substantial reductions in opportunistic and other infections during the HAART vs pre-HAART eras. In an editorial, Harwell and ObaroArticle discuss advances in the care of HIV-infected children and the challenge of ensuring optimal treatment for children throughout the world.

COMPLEMENT POLYMORPHISM AND MACULAR DEGENERATION

Inflammation likely plays a role in age-related macular degeneration (AMD), and data from case-control studies suggest an association between a complement factor H (CFH) gene polymorphism, Y402H, and AMD. Despriet and colleagues assessed this relationship and the modifying effects of smoking and serum markers of inflammation in a population-based cohort. The authors found the CFHY402H polymorphism in 36.2% of their study population, and they calculated a population-attributable risk for CFHY402H of 54%. Elevated levels of serum inflammatory markers and smoking added to the increased risk of AMD in persons with the Y402H allele.

SICKLE CELL DISEASE, NT-PROBNP LEVELS, AND MORTALITY

Brain natriuretic peptide levels are elevated in pulmonary artery hypertension. Machado and colleagues hypothesized that levels of plasma N-terminal-pro-brain natriuretic peptide (NT-proBNP) would correlate with the severity of pulmonary hypertension and mortality risk in patients with sickle cell disease and tested their hypothesis in 2 cohort studies of patients with sickle cell disease. The authors found that an NT-proBNP level greater than 160 pg/mL was common in patients with sickle cell pulmonary hypertension and was an independent predictor of mortality.

A PIECE OF MY MIND

“When physicians give counsel, they do not substitute their judgment for that of the patient or family. Instead, physicians work in partnership with patients and families to craft a mutually determined decision that best meets the demands of a particular situation.” From “The Physician's Counsel.”

MEDICAL NEWS & PERSPECTIVES

Unique ethical issues arise in designing clinical trials with placebo groups that include patients with advanced cancer or other terminal illnesses.

CLINICIAN'S CORNER

Mittelman reviews the epidemiology of hyperlipidemia, treatment, primary prevention in women and particularly African American women, and goals of therapy in his discussion of Ms T, a 39-year-old African American woman with elevated lipid levels.

ALZHEIMER DISEASE RISK IDENTIFICATION

An article in the Archives of Neurology reports that levels of cerebrospinal fluid β-amyloid 42—a biomarker for Alzheimer disease—decrease significantly with age, and this decline is accelerated in persons with the apolipoprotein E allele. Rosenberg discusses new insights from transgenic mouse models of Alzheimer disease and related dementias and their potential clinical applications.

AUDIO COMMENTARY

Dr DeAngelis summarizes and comments on this week's issue. Go to http://jama.ama-assn.org/misc/audiocommentary.dtl.

JAMA PATIENT PAGE

For your patients: Information about HIV infection in children.

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...